Table 3.
Comparison of IBSSI evolution (mean ± SD decrease between T0 and T1) with respect to concomitant conventional IBS treatment.
| Concomitant Treatment | Without Treatment | With Treatment | |||
|---|---|---|---|---|---|
| n | IBSSI Score | n | IBSSI Score | p-Value | |
| Antispasmodic | 96 | 119.5 ± 73.5 | 50 | 124.6 ± 74.1 | 0.70 |
| Antidiarrhoeic medication | 132 | 119.1 ± 75.6 | 14 | 141.7 ± 46.9 | 0.27 |
| Laxative medication | 123 | 125.0 ± 74.8 | 23 | 101.3 ± 64.2 | 0.16 |
| Antidepressants/benzodiazepines | 97 | 124.3 ± 71.3 | 49 | 115.2 ± 78.0 | 0.48 |
| Probiotics | 101 | 118.8 ± 75.9 | 44 | 126.0 ± 69.0 | 0.59 |
T0: baseline visit, T1: after the 2-month BBR–CUR supplementation follow-up visit.